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Angiotensinogen geneAbstract The pathogenesis of essential hypertension (EH) is affected by genetic and environmental
factors. Mutations in hypertension-related genes can affect blood pressure (BP) via alteration of salt
and water reabsorption by the nephron. The genes of the renin-angiotensin system (RAS) have been
extensively studied because of the well documented role of this system in the control of BP. It has
been previously shown that angiotensinogen (AGT) gene polymorphism could be associated with
increased risk of EH. The current study evaluated the frequency of AGT (M235T) polymorphism
in relation to EH in a group of Egyptian population. The study population included 83 hypertensive
patients and 60 age and sex matched healthy control subjects. Restriction fragment length polymor-
phism-Polymerase chain reaction (RFLP-PCR) was used for the analysis of M235T polymorphism
of AGT genes in peripheral blood samples of all patients and controls. The results revealed that
there was a positive risk of developing EH when having the T allele whether in homozygous or het-
erozygous state. It was concluded that there was an association between AGT (M235T) gene poly-
morphism and the risk of developing EH.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Cardiology.1. Introduction
Essential hypertension is a major risk factor for several cardio-
vascular diseases. It is a complex trait resulting from the interac-
tions of multiple genetic and environmental factors. Moreover,
not only genetic but also epigenetic inheritance plays a signiﬁ-
cant role. One can speculate that hypertension develops as a
consequence of ‘‘errors’’ in the well-coordinated regulatory
2 M.M. Shamaa et al.systems of blood pressure.1 This common disease-common var-
iant concept suggests that the genetic heterogeneity underlying
hypertension susceptibility could be relatively small. Therefore,
it makes sense that variation in genes related to hypertension
should be studied.2 In recent years, the research is directed to-
wards analysis of the disease on genetic level and explanation
of the genetic bases of this disorder. Development of powerful
and sensitive molecular techniques has resulted in widespread
endeavors to dissect the genetic factors and their molecular de-
fects accounting for hypertension in various populations. To-
day, the state of the art approach toward the diagnosis of
primary hypertension involves analysis of the genetic bases for
the disorder.3 The renin-angiotensin system (RAS) is a group
of related hormones that act together to regulate BP by main-
taining vascular tone and the balance of water and sodium.
Angiotensinogen (AGT) is among the components that are in-
volved in the activation/effector cascade of the RAS. It is sug-
gested that AGT (M235T) polymorphism may be the
functional genotype, as it affects the basal transcription rate of
AGT, which could explain the association of the M235T geno-
types with the plasma AGT concentration.4 Genetic polymor-
phisms in components of the RAS including AGT (M235T)
are suggested to be associated with the pathogenesis of EH.
However, obtained results are still debated.5
The analysis of RAS related genetic polymorphism of pa-
tients having EH has been carried out in Egyptian population
on a limited scale. So, this study aimed to determine the asso-
ciation of genetic polymorphisms of the angiotensinogen
(M235T) gene with EH in a cohort of genetically homogenous
EH patients and normotensive controls (case-control study).
2. Materials and methods
The current study included 83 EH patients (55 male, 28 female)
with mean age of 53.5 ± 7.4 years old. Also 60 healthy
subjects (32 male, 28 female) matching in age and sex
(51.3 ± 8.8 years old) were included as control group. The
patients were selected from the outpatient clinic of the
Cardiology Department, General Alexandria University
Hospital during the period between 2009 and 2010. A written
consent was obtained from all subjects accepting to participate
in the study for both the clinical part and the genetic study. All
subjects under study were subjected to thorough history taking
and clinical examination with special emphasis on BP and
BMI. Peripheral blood samples were collected from all subjects
and routine investigations were done including FBS, lipid pro-
ﬁle (total cholesterol, LDL – ch, HDL – ch and triglycerides)
and renal function tests (serum urea and creatinine).Table 1 The frequency of AGT (M235T) polymorphic genotypes i
Control (n= 60)
No. %
AGT genotypes
MM 41 68.3
MT 14 23.3
TT 5 8.3
v2 (p) 53.784a (<0.001)
v2: Chi square test.
a Statistically signiﬁcant at p 6 0.05.Essential hypertension was diagnosed in individuals with a
systolic blood pressure (SBP) > 140 mmHg and/or a diastolic
blood pressure (DBP) > 90 mmHg, for at least three consecu-
tive blood pressure measurements. Blood pressure was mea-
sured using a mercury sphygmomanometer after a rest for at
least 15 min in quiet condition and the pressure was determined
as the average of the three measurements. Secondary forms of
hypertension were excluded based on clinical history and labo-
ratory investigations. The normotensive controls were healthy
individuals with a negative history of hypertension and with a
SBP < 140 mmHg and DBP < 90 mmHg measured on three
separate occasions, also all study subjects were non diabetic with
normal renal functions.
2.1. Genotyping
DNA samples were isolated from peripheral blood lympho-
cytes by the standard phenol extraction method. The AGT
(M235T) polymorphisms was detected by RFLP PCR using
the following primers: 50-CCG TTT GTG CAG GGC CTG
GCT CTC T-30 as forward primer and 50-CAG GGT GCT
GTC CAC ACT GGA CCC C-30 as reverse primer. Ampliﬁca-
tion resulted in a 165-bp product which was digested using
restriction enzyme Pseudomonas syringae species (PsyI). Elec-
trophoresis on a 3% (w/v) agarose gel containing 0.5 lg/ml
ethidium bromide (Sigma–Aldrich, St. Louis, USA) and UV
transillumination were used for analysis.
Statistical Analysis was carried out using SPSS version 15.0
software and the following tests were used for data analysis:
Chi squared (v2) test, Monte Carlo Probability (MCP) and
Fisher’s Exact Probability (FEP) were used for analysis of cat-
egorical data, T-test was used for comparison between means,
Odds ratio (OR) was used for the measurement of association.3. Results
The results showed that the mean systolic and diastolic BP in
hypertensive patients were (145.28 ± 7.0 and 91.2 ±
2.15 mmHg) while in normotensive subjects (control group)
their corresponding values were (117.33 ± 4.27 and
79.17 ± 3.46 mmHg), respectively.
The results revealed that the frequency of the TT genotype
was signiﬁcantly (v2 = 53.784, P< 0.001) increased in hyper-
tensive patients. Furthermore, there was a positive risk of
developing EH when having the TT genotype and the results
were highly statistically signiﬁcant (OR = 36.217, P< 0.001)
for TT genotype compared to MM genotype (Tables 1 and 3).n normotensive subjects (control) and hypertensive patients.
Patients (n= 83) v2 (p)
No. %
12 14.5 43.334a (<0.001)
18 21.7 0.054 (0.816)
53 63.9 44.530a (<0.001)
Table 3 The risk of having AGT (M235T) polymorphism in relation to essential hypertension.
Control (n= 60) Patients (n= 83) OR 95 % CI (LL–UL) v2 (p)
No. % No. %
AGT genotypes
MM 41 68.3 12 14.5 – – –
MT 14 23.3 18 21.7 4.393a 1.700–11.353 9.869a (0.002)
TT 5 8.3 53 63.9 36.217a 11.816–111.008 53.920a (<0.001)
v2: Chi square test.
a Statistically signiﬁcant at p 6 0.05.
Table 2 The frequency of AGT M and T alleles in normotensive subjects (control) and hypertensive patients.
Control (n= 60) Patients (n= 83) v2 (p)
Freq. % Freq. %
AGT alleles
M 96 71.11 42 25.30 62.930a (<0.001)
T 39 28.97 124 74.78
v2: Chi square test.
a Statistically signiﬁcant at p 6 0.05.
Table 4 The risk of having T allele in relation to essential hypertension.
Control (n= 60) Patients (n= 83) OR 95 % CI (LL–UL) v2 (p)
Freq. No. % Freq. No. %
AGT alleles
M 96 71.11 42 25.30 7.267a 4.360–12.112 62.930a (<0.001)
T 39 28.97 124 74.78
v2: Chi square test.
a Statistically signiﬁcant at p 6 0.05.
Association between the Angiotensinogen (AGT) gene (M235T) polymorphism 3The frequency of T allele was signiﬁcantly (v2 = 62.930,
P< 0.001) increased in hypertensive patients. Furthermore,
there was a positive risk of developing EH when having the
T allele whether in homozygous or heterozygous state and
the results were highly statistically signiﬁcant (OR = 7.267,
P< 0.001) (Tables 2 and 4) (see Fig. 1).
4. Discussion
Cardiovascular diseases are rapidly emerging as a major health
concern in most developing countries, including Egypt, and
hypertension is one of the major preventable causes of morbid-Figure 1 Agarose gel (3%) electrophoresis for RFLP digested PCR
ladder base pair marker. Lane (2,3,5) represent restricted fragments of
represents unrestricted PCR product of patient with MM genotype (16
TT genotype(141 bp).ity and mortality from cardiovascular disease. Very recently,
Arafa and Ez-elarab6 calculated the prevalence of prehyperten-
sion and hypertension based on the data of 6671 individuals
from the EDHS 2008. The prevalence of prehypertension
and hypertension in Egypt were 57.2% and 17.6%, respec-
tively. Among Egyptian population, the responsiveness to
anti-hypertensive drugs is very poor, thus Prediction of drug
effect in a particular individual is a useful and important goal
as the extent of blood pressure lowering by anti-hypertensive
agents is difﬁcult to predict for individual patients, even when
evaluated in the context of biochemical or demographic
information. Genetic predictors (mainly single nucleotideproducts by PsyI restriction enzyme. Lane 1, represents 100 bp
PCR products of patients with MT genotype(141,165 bp). Lane 4,
5 bp). Lane 6,7, represent restricted PCR products of patients with
4 M.M. Shamaa et al.polymorphisms, SNPs) have been the focus of several studies
and are gaining much attention.6
The analysis of AGT (M235T) gene polymorphism of pa-
tients having EH has been carried out in Egyptian population
on a limited scale. The potential role of the AGT gene in pre-
disposition to hypertension is controversial. Since Jeunemaitre
et al.7 and Hata et al.8 previously reported higher prevalence of
the T235 allele among hypertensive than among normotensive
subjects, a large number of studies have explored the relation-
ship between AGT gene polymorphism and HT. In the current
study, the percentage of the TT genotype was signiﬁcantly
more frequent in hypertensive patients than in the control
group (p< 0.001). Moreover, the T allele was the risk allele
for hypertension where the study subjects carrying T allele
were at more than sevenfold higher risk for hypertension
(OR= 7.267, p< 0.001). The results of this study were in
accordance with studies that were conducted in the Malaysian
subjects,9 Han Chinese population,10 in Uzbek males,11 in
South India,12 Hong Kong Chinese population13 and in Tuni-
sian individuals.14
On the contrary, there was no signiﬁcant association be-
tween EH and AGT MT and TT genotypes in England,15,16
Caucasians,17 in the Mongolian population,18,19 Lebanese
population20 and in India.21 It has been suggested that the
population heterogeneity in the association of AGT (M235T)
polymorphism with essential hypertension may be due to sig-
niﬁcant variations of population backgrounds.22
This study suggests the existence of a linkage between AGT
gene polymorphism and the pathogenesis of essential hyper-
tension. These ﬁndings might help to manipulate the therapeu-
tic strategies in those cases as the potential for utility of genetic
characterization of individual patients as a predictor of anti-
hypertensive response has been realized.
5. Conclusion and recommendations
The present study provided an additional observation concerning
AGT (M235T) polymorphic genotypes in a sample of Egyptian
patients with EH. From this study it was concluded that:
1. The frequency of T allele was higher in hypertensive
patients (75%) as compared to control subjects (29%).
On the contrary, the M allele was less frequent in hyperten-
sive patients (25%) as compared to control subjects (71%).
2. Homozygosity for the AGTT allele was a risk factor for EH.
Moreover, the presence ofAGTTallele, whether in homozy-
gous or heterozygous state, was a risk factor for EH.
It is recommended that:
1. Future studies should investigate the inﬂuence of genetic
polymorphisms of the AGT (M235T) polymorphic geno-
types on response to anti-hypertensive therapy.
2. Future studies should evaluate the association of the AGT
(M235T) polymorphic genotypes in other human diseases
affected by alterations in the RAS.
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